| The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients M Janczura, S Sip, J Cielecka-Piontek Pharmaceutics 14 (4), 834, 2022 | 28 | 2022 |
| Chitosan as valuable excipient for oral and topical carvedilol delivery systems S Sip, M Paczkowska-Walendowska, N Rosiak, A Miklaszewski, ... Pharmaceuticals 14 (8), 712, 2021 | 20 | 2021 |
| Fixed-dose combination of NSAIDs and spasmolytic agents in the treatment of different types of pain—A practical review M Janczura, M Kobus-Moryson, S Sip, M Żarowski, A Wareńczak, ... Journal of clinical medicine 10 (14), 3118, 2021 | 15 | 2021 |
| Potential for Prebiotic Stabilized Cornus mas L. Lyophilized Extract in the Prophylaxis of Diabetes Mellitus in Streptozotocin Diabetic Rats S Sip, D Szymanowska, J Chanaj-Kaczmarek, K Skalicka-Woźniak, ... Antioxidants 11 (2), 380, 2022 | 13 | 2022 |
| Single-pill combination to improve hypertension treatment: pharmaceutical industry development M Paczkowska-Walendowska, S Sip, R Staszewski, J Cielecka-Piontek International Journal of Environmental Research and Public Health 19 (7), 4156, 2022 | 12 | 2022 |
| Determining antioxidant activity of Cannabis leaves extracts from different varieties—Unveiling nature’s treasure trove A Stasiłowicz-Krzemień, S Sip, P Szulc, J Cielecka-Piontek Antioxidants 12 (7), 1390, 2023 | 9 | 2023 |
| Budzy nska S Sip, D Szymanowska, J Chanaj-Kaczmarek, K Skalicka-Wozniak growth 32, 35, 2022 | 9 | 2022 |
| Zein as an effective carrier for hesperidin delivery systems with improved prebiotic potential S Sip, A Sip, A Miklaszewski, M Żarowski, J Cielecka-Piontek Molecules 28 (13), 5209, 2023 | 8 | 2023 |
| Haskap Berry Leaves (Lonicera caerulea L.)—The Favorable Potential of Medical Use S Sip, A Sip, P Szulc, J Cielecka-Piontek Nutrients 14 (19), 3898, 2022 | 8 | 2022 |
| Assisted Extraction with Cyclodextrins as a Way of Improving the Antidiabetic Activity of Actinidia Leaves S Sip, A Gościniak, P Szulc, J Walkowiak, J Cielecka-Piontek Pharmaceutics 14 (11), 2473, 2022 | 4 | 2022 |
| Enhancing antimicrobial activity of β-lactam antibiotic via functionalized mesoporous carbon-based delivery platforms J Goscianska, A Ejsmont, A Stasiłowicz-Krzemień, S Sip, ... Microporous and Mesoporous Materials 343, 112160, 2022 | 4 | 2022 |
| Aloe arborescens: In Vitro Screening of Genotoxicity, Effective Inhibition of Enzyme Characteristics for Disease Etiology, and Microbiological Activity K Pawłowicz, S Sip, T Plech, B Kaproń, J Kobus-Cisowska, ... Molecules 27 (7), 2323, 2022 | 4 | 2022 |
| Amorphous Form of Carvedilol Phosphate—The Case of Divergent Properties S Sip, N Rosiak, A Miklaszewski, P Talarska, E Dudziec, ... Molecules 26 (17), 5318, 2021 | 4 | 2021 |
| A Fisetin Delivery System for Neuroprotection: A Co-Amorphous Dispersion Prepared in Supercritical Carbon Dioxide S Sip, N Rosiak, A Sip, M Żarowski, K Hojan, J Cielecka-Piontek Antioxidants 13 (1), 24, 2023 | 3 | 2023 |
| The Antioxidant and Neuroprotective Potential of Leaves and Inflorescences Extracts of Selected Hemp Varieties Obtained with scCO2 A Stasiłowicz-Krzemień, S Sip, P Szulc, J Walkowiak, J Cielecka-Piontek Antioxidants 12 (10), 1827, 2023 | 3 | 2023 |
| Prunus padus L. as a source of functional compounds–antioxidant activity and antidiabetic effect A Telichowska, J Kobus-Cisowska, J Cielecka-Piontek, S Sip, ... Emirates Journal of Food and Agriculture 34 (2), 135-143, 2022 | 2 | 2022 |
| Haskap Berry Leaves (Lonicera caerulea L.)—The Favorable Potential of Medical Use. Nutrients 2022, 14, 3898 S Sip, A Sip, P Szulc, J Cielecka-Piontek s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| Oleanolic Acid Dimers with Potential Application in Medicine—Design, Synthesis, Physico-Chemical Characteristics, Cytotoxic and Antioxidant Activity A Günther, P Zalewski, S Sip, P Ruszkowski, B Bednarczyk-Cwynar International Journal of Molecular Sciences 25 (13), 6989, 2024 | | 2024 |
| Exploring Beneficial Properties of Haskap Berry Leaf Compounds for Gut Health Enhancement S Sip, A Sip, P Szulc, M Selwet, M Żarowski, B Czerny, J Cielecka-Piontek Antioxidants 13 (3), 357, 2024 | | 2024 |
| STABILITY OF API AS A KEY PARAMETER FOR NEW FORMULATION DEVELOPMENT--A CASE STUDY OF ROSUVASTATIN CALCIUM. S Sip, P ZALEWSKI, A PAŁUBICKA, J Cielecka-Piontek Acta Poloniae Pharmaceutica 80 (5), 2023 | | 2023 |
